Clearmind Medicine Revenue vs. Total Debt

CMND Stock  USD 1.13  0.04  3.67%   
Based on the measurements of profitability obtained from Clearmind Medicine's financial statements, Clearmind Medicine Common may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in April. Profitability indicators assess Clearmind Medicine's ability to earn profits and add value for shareholders.
 
Total Revenue  
First Reported
2010-12-31
Previous Quarter
0.0
Current Value
0.0
Quarterly Volatility
0.0
 
Credit Downgrade
 
Yuan Drop
 
Covid
At present, Clearmind Medicine's Payables Turnover is projected to increase slightly based on the last few years of reporting. The current year's Cash Per Share is expected to grow to 2.36, whereas Book Value Per Share is forecasted to decline to 0.80.
For Clearmind Medicine profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Clearmind Medicine to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Clearmind Medicine Common utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Clearmind Medicine's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Clearmind Medicine Common over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clearmind Medicine. If investors know Clearmind will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clearmind Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.69)
Return On Assets
(0.54)
Return On Equity
(2.57)
The market value of Clearmind Medicine Common is measured differently than its book value, which is the value of Clearmind that is recorded on the company's balance sheet. Investors also form their own opinion of Clearmind Medicine's value that differs from its market value or its book value, called intrinsic value, which is Clearmind Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clearmind Medicine's market value can be influenced by many factors that don't directly affect Clearmind Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clearmind Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clearmind Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clearmind Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Clearmind Medicine Common Total Debt vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Clearmind Medicine's current stock value. Our valuation model uses many indicators to compare Clearmind Medicine value to that of its competitors to determine the firm's financial worth.
Clearmind Medicine Common is currently under evaluation in revenue category among its peers. It is rated below average in total debt category among its peers . At present, Clearmind Medicine's Total Revenue is projected to stay steady based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Clearmind Medicine by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Clearmind Revenue vs. Competition

Clearmind Medicine Common is currently under evaluation in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 16.93 Million. Clearmind Medicine adds roughly 0.0 in revenue claiming only tiny portion of equities under Health Care industry.

Clearmind Total Debt vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Clearmind Medicine

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
null
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Clearmind Medicine

Total Debt

 = 

Bonds

+

Notes

 = 
53.14 K
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.

Clearmind Total Debt vs Competition

Clearmind Medicine Common is rated below average in total debt category among its peers. Total debt of Health Care industry is currently estimated at about 2 Billion. Clearmind Medicine adds roughly 53,142 in total debt claiming only tiny portion of equities under Health Care industry.
Total debt  Workforce  Capitalization  Revenue  Valuation

Clearmind Medicine Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Clearmind Medicine, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Clearmind Medicine will eventually generate negative long term returns. The profitability progress is the general direction of Clearmind Medicine's change in net profit over the period of time. It can combine multiple indicators of Clearmind Medicine, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-19.1 K-18.2 K
Operating Income-5.7 M-5.4 M
Net Loss-4.7 M-5 M
Income Before Tax-4.4 M-4.6 M
Total Other Income Expense Net922.8 K968.9 K
Net Loss-8.5 M-8 M
Net Loss-4.7 M-4.5 M
Income Tax Expense434.7 K456.4 K
Net Interest Income270.3 K283.8 K
Interest Income311.9 K327.5 K
Change To Netincome2.9 MM
Net Loss(1.42)(1.49)
Income Quality 1.06  0.95 
Net Income Per E B T 0.97  0.83 

Clearmind Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Clearmind Medicine. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Clearmind Medicine position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Clearmind Medicine's important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in Clearmind Medicine without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Manager Now

   

Portfolio Manager

State of the art Portfolio Manager to monitor and improve performance of your invested capital
All  Next Launch Module

Use Investing Themes to Complement your Clearmind Medicine position

In addition to having Clearmind Medicine in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Rentals Thematic Idea Now

Rentals
Rentals Theme
Companies providing rental and leasing services to public and business. The Rentals theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Rentals Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Clearmind Medicine Common is a strong investment it is important to analyze Clearmind Medicine's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Clearmind Medicine's future performance. For an informed investment choice regarding Clearmind Stock, refer to the following important reports:
Check out Trending Equities.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
To fully project Clearmind Medicine's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Clearmind Medicine Common at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Clearmind Medicine's income statement, its balance sheet, and the statement of cash flows.
Potential Clearmind Medicine investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Clearmind Medicine investors may work on each financial statement separately, they are all related. The changes in Clearmind Medicine's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Clearmind Medicine's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.